Sociodemographic predictors of COVID-19 vaccine hesitancy and leading concerns with COVID-19 vaccines among pregnant women at a South Texas clinic

被引:8
|
作者
Sutanto, Michelle Y. [1 ]
Hosek, Meredith G. [1 ]
Stumpff, Sierra K. [1 ]
Neuhoff, Barbara K. [2 ]
Hernandez, Brian S. [3 ]
Wang, Zhu [3 ]
Ramsey, Patrick S. [2 ]
Boyd, Angela R. [2 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Joe R & Teresa Lozano Long Sch Med, San Antonio, TX 78229 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Ctr Pregnancy & Newborn Res, Dept Obstet & Gynecol, San Antonio, TX 78229 USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Joe R & Teresa Lozano Long Sch Med, Dept Populat Hlth Sci, San Antonio, TX 78229 USA
来源
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE | 2022年 / 35卷 / 26期
关键词
Vaccine hesitancy; COVID-19; SARS-COV-2; vaccination; pregnancy;
D O I
10.1080/14767058.2022.2128652
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective COVID-19 vaccination rates among pregnant women remain low, despite increased risk of COVID-19-related illness and death and demonstrated vaccine safety and efficacy in this population. The objective of this study is to identify sociodemographic predictors of COVID-19 vaccine hesitancy and elucidate important concerns among the pregnant population in light of evolving conversations regarding COVID-19. Methods A prospective survey of pregnant women at a single urban clinic in South Texas was conducted August to September 2021 to identify predictors of COVID-19 vaccine hesitancy among the pregnant population. Collected variables included demographics, COVID-19 beliefs, tetanus-diphtheria-pertussis (Tdap)/influenza vaccine hesitancy, and primary vaccine concerns. Statistical analyses included Fisher's exact test, asymptotic two-sample Brown-Mood median test, and multinomial logistic regression. Results One hundred and nine participants completed the survey, 35 vaccinated and 74 unvaccinated, with a response rate of 91.6%. Women who were COVID-19 vaccine hesitant were more likely to be younger (28.0 vs. 31.0 years, p < .004) and further along in pregnancy (30.0 vs. 20.0 weeks, p = .001). They were also more likely to report influenza (odds ratio (OR) 6.3; 95% confidence interval (CI) 2.5-17.1) and Tdap (OR 4.1; 95% CI 1.75-10.7) vaccine hesitancy. Furthermore, women who were vaccine hesitant were more likely to believe they did not have enough information to confidently make their decision (OR 4.0; 95% CI 1.4-11.4). Primary concerns with COVID-19 vaccines included: short- and long-term side effects on the pregnancy, personal long-term side effects, and harmful ingredients. Conclusions COVID-19 vaccine hesitant pregnant women were more likely to be younger, hesitant toward other vaccines, and concerned with pregnancy impact and harmful ingredients. Personal knowledge of other vaccinated pregnant women was associated with significantly higher vaccine acceptance rates. Access to vaccines and concerns about quality control were not cited as reasons for vaccine hesitancy, in contrast to earlier studies on this topic.
引用
收藏
页码:10368 / 10374
页数:7
相关论文
共 50 条
  • [41] COVID-19 vaccines inequity and hesitancy among African Americans
    Sina-Odunsi, Ayobami Jadesola
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 12
  • [42] Determinants of COVID-19 Vaccination Hesitancy among Romanian Pregnant Women
    Citu, Ioana Mihaela
    Citu, Cosmin
    Gorun, Florin
    Motoc, Andrei
    Gorun, Oana Maria
    Burlea, Bogdan
    Bratosin, Felix
    Tudorache, Emanuela
    Margan, Madalin-Marius
    Hosin, Samer
    Malita, Daniel
    VACCINES, 2022, 10 (02)
  • [43] Pharmacovigilance of COVID-19 Vaccines in Pregnant and Lactating Women
    Silva, Ana Marta
    Ribeiro-Vaz, Ines
    Ferreira-da-Silva, Renato
    Cruz-Correia, Ricardo
    Polonia, Jorge
    Bernardes, Joao
    ACTA MEDICA PORTUGUESA, 2021, 34 (12) : 807 - 809
  • [44] Patient concerns and physician strategies for addressing COVID-19 vaccine hesitancy
    Melnikow, Joy
    Padovani, Andrew
    Zhang, Jingwen
    Miller, Marykate
    Gosdin, Melissa
    Loureiro, Sabrina
    Daniels, Brock
    VACCINE, 2024, 42 (14) : 3300 - 3306
  • [45] COVID-19 Vaccine Hesitancy Among Medical Students: The Next COVID-19 Challenge in Wuhan, China
    Gao, Xudong
    Li, Haiyan
    He, Wenjie
    Zeng, Wen
    DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS, 2021, 17
  • [46] COVID-19 vaccine hesitancy among women leaving jails: A qualitative study
    Geana, Mugur V.
    Anderson, Sherri
    Ramaswamy, Megha
    PUBLIC HEALTH NURSING, 2021, 38 (05) : 892 - 896
  • [47] COVID-19 vaccine hesitancy in perinatal women: a cross sectional survey
    Mohan, Suruchi
    Reagu, Shuja
    Lindow, Stephen
    Alabdulla, Majid
    JOURNAL OF PERINATAL MEDICINE, 2021, 49 (06) : 678 - 685
  • [48] COVID-19 vaccine hesitancy among pregnant women: a systematic review and meta-analysis
    Bhattacharya, Oashe
    Siddiquea, Bodrun Naher
    Shetty, Aishwarya
    Afroz, Afsana
    Billah, Baki
    BMJ OPEN, 2022, 12 (08):
  • [49] Associations between COVID-19 Death Exposure and COVID-19 Vaccine Hesitancy and Vaccine Uptake
    Andersen, Jennifer A.
    Scott, Aaron J.
    Rowland, Brett
    Willis, Don E.
    McElfish, Pearl A.
    SOUTHERN MEDICAL JOURNAL, 2023, 116 (07) : 519 - 523
  • [50] Vaccine hesitancy and COVID-19 immunization among rural young adults
    Mann, Sara
    Christini, Kaila
    Chai, Yan
    Chang, Chun-Pin
    Hashibe, Mia
    Kepka, Deanna
    PREVENTIVE MEDICINE REPORTS, 2022, 28